Common Contracts
16 similar Underwriting Agreement contracts by HiTek Global Inc., Galmed Pharmaceuticals Ltd., Exicure, Inc., others
3,450,000 Shares Five Star Bancorp Common Stock UNDERWRITING AGREEMENT March 28, 2024Underwriting Agreement • March 29th, 2024 • Five Star Bancorp • State commercial banks
UNDERWRITING AGREEMENTUnderwriting Agreement • October 4th, 2021 • XORTX Therapeutics Inc. • Pharmaceutical preparations • New York
XORTX Therapeutics Inc., a company organized under the laws of British Columbia (the “Company”), proposes to issue and sell, severally and not jointly, to A.G.P./Alliance Global Partners (the “Representative”) and the other underwriters named on Schedule I hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) (i) an aggregate of [__] common share units (the “Common Share Units”), with each Common Share Unit consisting of (A) one common share (each a “Firm Share” and collectively the “Firm Shares”), no par value per share, of the Company (the “Shares”), and (B) a warrant to purchase [__] Shares (each a “Firm Warrant” and collectively the “Firm Warrants”) and (ii) an aggregate of [ ] pre-funded warrant units (the “Pre-Funded Warrant Units”), with each Pre-Funded Warrant Unit consisting of (A) a pre-funded warrant to purchase [__] Shares at an exercise
19,354,840 Shares of Common Stock SEELOS THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • May 21st, 2021 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
Seelos Therapeutics, Inc., a corporation organized and existing under the laws of the State of Nevada (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 19,354,840 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (the “Common Stock”). The Company also proposes to issue and sell to the several Underwriters up to an additional 2,903,226 shares (the “Additional Shares”) of Common Stock at the option of the Underwriters as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the “Shares.” Guggenheim Securities, LLC (“Guggenheim Securities”) is acting as representative (the “Representative”) of the several Underwriters in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
1,222,222 Shares of Common Stock ICAD, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2021 • Icad Inc • Surgical & medical instruments & apparatus • New York
iCAD, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 1,222,222 shares (the “Firm Shares”) of its common stock, par value $0.01 per share (the “Common Stock”). The Company also proposes to issue and sell to the several Underwriters up to an additional 171,516 shares (the “Additional Shares”) of Common Stock at the option of the Underwriters as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the “Shares.” Guggenheim Securities, LLC (“Guggenheim Securities”) is acting as representative (the “Representative”) of the several Underwriters in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
2,197,803 Shares Galmed Pharmaceuticals Ltd. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • February 18th, 2021 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
Galmed Pharmaceuticals Ltd., a corporation organized under the laws of the State of Israel (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”), an aggregate of 2,197,803 ordinary shares of the Company, par value NIS 0.01 per share (the “Ordinary Shares”). The 2,197,803 Ordinary Shares to be sold by the Company are called the “Firm Shares”. In addition, the Company has granted to the Underwriters an option to purchase up to an additional 329,670 Ordinary Shares (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
TREVENA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 13th, 2020 • Trevena Inc • Pharmaceutical preparations • New York
Trevena, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 21,739,131 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (the “Common Stock”). The Company also proposes to issue and sell to the several Underwriters up to an additional 3,260,869 shares (the “Additional Shares”) of Common Stock at the option of the Underwriters as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the “Shares.” Guggenheim Securities, LLC (“Guggenheim Securities”) is acting as representative (the “Representative”) of the several Underwriters in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
UNDERWRITING AGREEMENTUnderwriting Agreement • August 6th, 2020 • HiTek Global Inc. • Services-prepackaged software • New York
This Agreement (the “Agreement”) constitutes the agreement between Hitek Global Inc., a Cayman Islands company (collectively with its subsidiaries and its variable interest entities, the “Company”), with the several underwriters (such underwriters, for whom Newbridge Securities Corporation, a Virginia corporation, is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, reference to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] ordinary shares, par value $0.0001 “Ordinary Shares”), of the Company (the “Firm Shares”). The Company has also granted to the several Underwriters an option to subscribe for and purchase up to [●] additional Ordinary Shares, on the terms and for the purposes set forth in Section 1(B) hereof (the “Option Sh
30,303,030 Shares of Common Stock SOLENO THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 26th, 2020 • Soleno Therapeutics Inc • Electromedical & electrotherapeutic apparatus • New York
Soleno Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 30,303,030 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (the “Common Stock”). The Company also proposes to issue and sell to the several Underwriters up to an additional 4,545,454 shares (the “Additional Shares”) of Common Stock at the option of the Underwriters as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the “Shares.” Guggenheim Securities, LLC (“Guggenheim Securities”) is acting as representative (the “Representative”) of the several Underwriters in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
UNDERWRITING AGREEMENTUnderwriting Agreement • February 28th, 2020 • HiTek Global Inc. • Services-prepackaged software • New York
This Agreement (the “Agreement”) constitutes the agreement between Hitek Global, Inc., a Cayman Islands company (collectively with its subsidiaries and its variable interest entities, the “Company”), with the several underwriters (such underwriters, for whom Newbridge Securities Corporation, a Virginia corporation, is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, reference to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] ordinary shares, par value $0.0001 “Ordinary Shares”), of the Company (the “Firm Shares”). The Company has also granted to the several Underwriters an option to purchase up to [●] additional Ordinary Shares, on the terms and for the purposes set forth in Section 1(B) hereof (the “Option Shares”). The Firm
UNDERWRITING AGREEMENTUnderwriting Agreement • January 7th, 2020 • HiTek Global Inc. • Services-prepackaged software • New York
This Agreement (the “Agreement”) constitutes the agreement between Hitek Global, Inc., a Cayman Islands company (collectively with its subsidiaries and its variable interest entities, the “Company”), with the several underwriters (such underwriters, for whom Newbridge Securities Corporation, a Virginia corporation, is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, reference to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] ordinary shares, par value $0.0001 “Ordinary Shares”), of the Company (the “Firm Shares”). The Company has also granted to the several Underwriters an option to purchase up to [●] additional Ordinary Shares, on the terms and for the purposes set forth in Section 1(B) hereof (the “Option Shares”). The Firm
10,000,000 Shares of Common Stock EXICURE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 23rd, 2019 • Exicure, Inc. • Pharmaceutical preparations • New York
Exicure, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 10,000,000 shares (the “Firm Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”). The Company also proposes to issue and sell to the several Underwriters up to an additional 1,500,000 shares (the “Additional Shares”) of Common Stock at the option of the Underwriters as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the “Shares.” Guggenheim Securities, LLC (“Guggenheim Securities”) is acting as representative (the “Representative”) of the several Underwriters in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2019 • HiTek Global Inc. • Services-prepackaged software • New York
This Agreement (the “Agreement”) constitutes the agreement between Hitek Global, Inc., a Cayman Islands company (collectively with its subsidiaries and its variable interest entities, the “Company”), with the several underwriters (such underwriters, for whom Newbridge Securities Corporation, a Virginia corporation, is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, reference to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] Class A ordinary shares, par value $0.0001 Ordinary Shares”), of the Company (the “Firm Shares”). The Company has also granted to the several Underwriters an option to purchase up to [●] additional Ordinary Shares, on the terms and for the purposes set forth in Section 1(B) hereof (the “Option Shares”). Th
5,000,000 Shares Galmed Pharmaceuticals Ltd. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • June 21st, 2018 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
Galmed Pharmaceuticals Ltd., a corporation organized under the laws of the State of Israel (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”), an aggregate of 5,000,000 ordinary shares of the Company, par value NIS 0.01 per share (the “Ordinary Shares”). The 5,000,000 Ordinary Shares to be sold by the Company are called the “Firm Shares”. In addition, the Company has granted to the Underwriters an option to purchase up to an additional 750,000 Ordinary Shares (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
Common Stock rEVO BIOLOGICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 4th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • New York
RICEBRAN TECHNOLOGIES UNDERWRITING AGREEMENTUnderwriting Agreement • June 20th, 2014 • RiceBran Technologies • Grain mill products • New York
RiceBran Technologies, a California corporation (the “Company”), confirms its agreement, subject to the terms and conditions set forth herein, with each of the underwriters listed on Schedule A hereto (collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), to sell and issue to the Underwriters an aggregate of 1,417,500 shares (the “Shares”) of common stock, no par value per share, of the Company (the “Common Stock”), together with warrants to purchase an aggregate of 708,750 shares of Common Stock at an exercise price equal to $5.87 per share (each a “Warrant” and collectively, the “Warrants”). Each Share shall be accompanied by a Warrant to purchase one-half of an additional share of Common Stock.
SHARES OF COMMON STOCK ULTIMATE ESCAPES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 11th, 2010 • Ultimate Escapes, Inc. • Hotels & motels • New York
